Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Term Antibiotic Treatment for Acute Uncomplicated Pyelonephritis in Women
NCT01390623Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jul 2011
- Primary completion
- Jul 2013
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftriaxone and cefixime in acute pyelonephritis, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Microbiological cure at the 9th day at 9 days. Started Jul 2011; status: completed.
02
Drugs
ceftriaxonecefixime
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on NCT01390623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390623.